90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients

Inflammatory bowel diseases (IBD), comprising Crohn’s disease (CD) and Ulcerative Colitis (UC), are multifactorial disorders characterized by a chronic inflammatory status with the secretion of cytokines and immune mediators. Biologic drugs targeting pro-inflammatory cytokines, such as infliximab, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesole, Pasqua Letizia, Liso, Marina, Donghia, Rossella, Guerra, Vito, Lippolis, Antonio, Mastronardi, Mauro, Iacovazzi, Palma Aurelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966915/
https://www.ncbi.nlm.nih.gov/pubmed/36835367
http://dx.doi.org/10.3390/ijms24043955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966915/
https://www.ncbi.nlm.nih.gov/pubmed/36835367
http://dx.doi.org/10.3390/ijms24043955

Ejemplares similares